CVKD logo

CVKDCadrenal Therapeutics, Inc.

$3.87
$0.165
(4.46%)
Today
Updated: 10:18 AM EDT
Mkt Cap$10.61M
Vol8,622.00

About

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
5

Frequently Asked Questions

What is Market Cap of Cadrenal Therapeutics Inc?
What is the 52-week high for Cadrenal Therapeutics Inc?
What is the 52-week low for Cadrenal Therapeutics Inc?
What is Cadrenal Therapeutics Inc stock price today?
What was Cadrenal Therapeutics Inc stock price yesterday?
What is the PE ratio of Cadrenal Therapeutics Inc?
What is the Price-to-Book ratio of Cadrenal Therapeutics Inc?
What is the 50-day moving average of Cadrenal Therapeutics Inc?
How many employees does Cadrenal Therapeutics Inc have?

Advertisement|Remove ads.